Scorpion Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- October 26, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $108,000,000
Company Info
- Founders
- Gary D. Glick
- Company Description
- Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
- Market
- Precision Oncology
- Location
- Boston, MA, USA
- Coinvestors
- Abingworth, Atlas Venture, Omega Funds, Partners HealthCare Innovation, Vida Ventures